NYSE:RFL Rafael (RFL) Stock Price, News & Analysis → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free RFL Stock Alerts $1.70 -0.01 (-0.58%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$1.67▼$1.7550-Day Range$1.66▼$1.8752-Week Range$1.44▼$2.52Volume7,625 shsAverage Volume24,488 shsMarket Capitalization$41.79 millionP/E Ratio17.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Rafael alerts: Email Address Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" About Rafael Stock (NYSE:RFL)Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesApril 25, 2024 | msn.comRafael Devers returns with a bang, helps Red Sox roll GuardiansApril 25, 2024 | msn.comRafael Nadal continues to face injury ‘limitations’ and is unsure if he will compete at French OpenApril 26, 2024 | Tranzact (Ad)What is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. April 25, 2024 | msn.comRed Sox win: Rafael Devers puts on show in return, Connor Wong homers twiceApril 25, 2024 | msn.comRafael Nadal unsure about French Open in latest fitness bombshell: ‘Not going to play in Paris if…’April 25, 2024 | msn.comFormer San Rafael officer in abuse case seeks reinstatementApril 25, 2024 | msn.comConnor Wong homers twice, Rafael Devers connects for solo shot as Red Sox hammer Guardians 8-0April 25, 2024 | msn.comWhy Rafael Devers’ HR, 3 hits weren’t most encouraging part of Red Sox returnApril 26, 2024 | Tranzact (Ad)What is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. April 24, 2024 | msn.comSan Rafael scooter driver injured downtownApril 24, 2024 | msn.comRafael Devers returns to Red Sox lineup, but Masataka Yoshida sits againApril 24, 2024 | msn.comAmerican teen sensation Darwin Blanch ‘obviously nervous’ ahead of Rafael Nadal matchApril 24, 2024 | msn.comThe Helix School in San Rafael growing with the communityApril 24, 2024 | msn.comRafael Nadal says he is not 100% fit ahead of Madrid debut. Spaniard still unsure about playing French OpenApril 23, 2024 | msn.comRafael Devers injury return date will relieve Red Sox fansApril 23, 2024 | msn.comNo Rafael Devers Again On TuesdayApril 23, 2024 | msn.comRafael Nadal and Roger Federer towards the same touching fateApril 23, 2024 | sportsbookwire.usatoday.comRafael Nadal: Mutua Madrid Open Betting Odds and PreviewApril 23, 2024 | msn.comRed Sox lineup: Alex Cora explains why Rafael Devers, Masataka Yoshida are outApril 23, 2024 | finance.yahoo.comMadison Group Announces Plans for Master-Planned Community on Eglinton Ave. East By World-Renowned Rafael Viñoly ArchitectsApril 23, 2024 | forbes.comNovak Djokovic ‘Hopes To Play Rafael Nadal At Least One More Time Before He Retires’April 23, 2024 | msn.comFans crazy for Roddick's bold prediction on Rafael Nadal!April 23, 2024 | msn.comRafael Nadal's Laver Cup Odyssey Echoes Roger Federer's FarewellApril 22, 2024 | msn.comCould Mexico's Rafael Márquez really be Xavi Hernández 's successor at Barcelona?April 22, 2024 | msn.comRafael Nadal returns to Laver Cup!April 22, 2024 | sportsbookwire.usatoday.comMutua Madrid Open: Darwin Blanch vs. Rafael Nadal Betting Odds and Match PreviewApril 22, 2024 | msn.comRafael Devers, Tyler O’Neill inching closer to playing again for the Red SoxSee More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/26/2024Next Earnings (Estimated)6/11/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Real estate Sub-IndustryN/A Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.10 Trailing P/E Ratio17.00 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins776.36% Pretax Margin827.64% Return on Equity-4.31% Return on Assets-4.22% Debt Debt-to-Equity RatioN/A Current Ratio23.01 Quick Ratio23.01 Sales & Book Value Annual Sales$280,000.00 Price / Sales149.24 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.43Miscellaneous Outstanding Shares24,580,000Free Float22,199,000Market Cap$41.79 million OptionableOptionable Beta1.32 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 68)Founder & Executive Chairman Comp: $40kMr. William Conkling (Age 52)CEO & President Comp: $751.95kMr. David A. Polinsky Esq. (Age 52)Chief Financial Officer Comp: $363.3kMs. Barbara A. Ryan (Age 64)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryDr. John Mayer Goldberg M.D. (Age 51)Chief Medical Officer Ms. Joyce J. Mason Esq. (Age 65)Corporate Secretary More ExecutivesKey CompetitorsAspira Women's HealthNASDAQ:AWHNKGen BiotechNYSE:NKGNPrenetics GlobalNASDAQ:PREBolt BiotherapeuticsNASDAQ:BOLTCarmellNASDAQ:CTCXView All CompetitorsInstitutional OwnershipAcuitas Investments LLCBought 88,940 shares on 2/2/2024Ownership: 1.315%Simplex Trading LLCBought 2,500 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed in 2024? Rafael's stock was trading at $1.83 at the start of the year. Since then, RFL shares have decreased by 7.1% and is now trading at $1.70. View the best growth stocks for 2024 here. Are investors shorting Rafael? Rafael saw a decrease in short interest in March. As of March 31st, there was short interest totaling 38,800 shares, a decrease of 36.0% from the March 15th total of 60,600 shares. Based on an average daily trading volume, of 26,500 shares, the days-to-cover ratio is presently 1.5 days. View Rafael's Short Interest. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) posted its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.08) earnings per share (EPS) for the quarter. The firm earned $0.07 million during the quarter. Rafael had a negative trailing twelve-month return on equity of 4.31% and a net margin of 776.36%. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RFL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.